Clinical trial
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally…
NCT00093652 · Roswell Park Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00093652 |
|---|---|
| Title | Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer |
| Official title | ZD1839 (IRESSA®) With Oxaliplatin and Radiotherapy for Esophageal Carcinoma. A Phase I/II Study With Biologic Correlates |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | gefitinib, oxaliplatin, conventional surgery, neoadjuvant therapy, radiation therapy |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2006 |
| First posted | Oct 8, 2004 |
| Last update posted | Oct 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: